Erythropoietin and cancer, a double-edged sword

Domenico Ribatti

Research output: Contribution to journalArticle


This editorial is focused on the double controversial action of erythropoietin, acting as anticancer agent and as a promoting cancer agent.

Original languageEnglish
Pages (from-to)1-4
Number of pages4
JournalLeukemia Research
Issue number1
Publication statusPublished - Jan 2009


  • Erythropoietin
  • Erythropoietin receptor
  • Erythropoietin-stimulating agents
  • Tumor progression

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Erythropoietin and cancer, a double-edged sword'. Together they form a unique fingerprint.

  • Cite this